Cargando…
Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises
There are no commercially available effective antiviral medications or vaccines to deal with novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for new and efficacious treatment options for COVID-19. Most COVID-19 deaths result from acute respiratory distress syndr...
Autores principales: | Rezakhani, Leila, Kelishadrokhi, Ali Fatahian, Soleimanizadeh, Arghavan, Rahmati, Shima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658620/ https://www.ncbi.nlm.nih.gov/pubmed/33189639 http://dx.doi.org/10.1016/j.chemphyslip.2020.105009 |
Ejemplares similares
-
Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis
por: Cheng, Jin, et al.
Publicado: (2022) -
Comparison of therapeutic effects of encapsulated Mesenchymal stem cells in Aloe vera gel and Chitosan-based gel in healing of grade-II burn injuries
por: Sharifi, Esmaeel, et al.
Publicado: (2021) -
Molecular characterization, serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections
por: Ranjbar, Reza, et al.
Publicado: (2019) -
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
por: Lotfy, Ahmed, et al.
Publicado: (2023) -
Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes
por: Guy, Reut, et al.
Publicado: (2020)